No Data
No Data
Baiben Healthcare (02293.HK) received an increase of 64,000 common shares by Xi Xiaozhu, worth approximately HK$41,600
On April 9, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 9, Xi Xiaozhu increased his common stock holdings of $100 Healthcare (02293.HK) by $64,000 at an average price of HK$0.65 per share on April 5, worth about HK$41,600. After the increase in holdings, Xi Xiaozhu's latest shareholding was 271 million shares, and the good position ratio rose from 67.28% to 67.30%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. Directors and directors of listed companies
Baiben Healthcare (02293.HK) received 600,000 additional shares of common stock by Xi Xiaozhu, worth approximately HK$389,400
On April 9, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 9, Xi Xiaozhu increased his common stock holdings of $100ben Healthcare (02293.HK) by $600,000 at an average price of HK$0.649 per share on April 3, worth about HK$389,400. After the increase in holdings, Xi Xiaozhu's latest shareholding was 271 million shares, and the good position ratio rose from 67.13% to 67.28%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. directors of listed companies and
BAMBOOSHEALTH: Interim Report 2023/2024
BAMBOOSHEALTH To Go Ex-Dividend On March 11th, 2024 With 0.05 HKD Dividend Per Share
February 28th - $BAMBOOSHEALTH(02293.HK)$ is trading ex-dividend on March 11th, 2024. Shareholders of record on March 12th, 2024 will receive 0.05 HKD dividend per share on March 22nd, 2024. The e
100 Healthcare (02293) will pay an interim dividend of HK$0.05 per share on March 22
Baiben Healthcare (02293) announced that the company will pay an interim dividend of 0 per share on March 22, 2024...
Medium-term net profit of Baiben Healthcare (02293.HK) decreased by 44.1% to HK$17.1 million
On February 27, GLONGHUI | Baiben Healthcare (02293.HK) announced that for the six months ended December 31, 2023, revenue was approximately HK$49.7 million, a year-on-year decrease of about 26.6%; profit attributable to the company's equity holders was approximately HK$17.1 million, a decrease of about 44.1% year-on-year. Basic and diluted earnings per share were HK4.28 cents.
No Data